Phase I clinical trial of peptide vaccine derived from HSP105 and analysis of immune response in vaccinated patients

被引：0
|
作者：
Shimizu, Yasuhiro [1 ]
Yoshikawa, Toshiaki [1 ]
Syoda, Kayoko [1 ]
Nosaka, Kazuto [1 ]
Shimomura, Manami [1 ]
Mizuno, Shoichi [1 ]
Wada, Satoshi [2 ]
Fujimoto, Yuki [2 ]
Kohashi, Kenichi [3 ]
Kojima, Takashi [4 ]
Endo, Itaru [5 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] EPOC, Natl Canc Ctr, Div Canc Immunother, Tokyo, Japan
[2] Kanagawa Canc Ctr, Res Inst, Dept Canc Immunother, Yokohama, Kanagawa, Japan
[3] Kyushu Univ, Grad Sch Med, Dept Anat Path Pathol Sci, Fukuoka, Fukuoka, Japan
[4] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[5] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol Surg, Yokohama, Kanagawa, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3206
引用
收藏
页码：1334 / 1334
页数：1
相关论文
共 50 条
  • [31] PHASE I CLINICAL TRIAL OF VACCINATION OF MPHOSPH1 AND DEPDC1 EPITOPE PEPTIDE VACCINE FOR PATIENTS WITH BLADDER CANCER
    Obara, Wataru
    Kanehira, Mitsugu
    Takata, Ryo
    Tsunoda, Takuya
    Yoshida, Koji
    Katagiri, Toyomasa
    Nakamura, Yusuke
    Fujioka, Tomoaki
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 349 - 349
  • [32] Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial
    Pagnon, Anke
    Carre, Christophe
    Aguirre, Marion
    Chautard, Emilie
    Gimenez, Sophie
    Raynal, Franck
    Feroldi, Emmanuel
    Scott, Paul
    Modjarrad, Kayvon
    Vangelisti, Manuel
    Mantel, Nathalie
    [J]. EBIOMEDICINE, 2024, 108
  • [33] Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
    Bjoern, Jon
    Iversen, Trine Zeeberg
    Nitschke, Nikolaj Juul
    Andersen, Mads Hald
    Svane, Inge Marie
    [J]. CYTOTHERAPY, 2016, 18 (08) : 1043 - 1055
  • [34] Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial
    Lorentzen, Cathrine Lund
    Martinenaite, Evelina
    Kjeldsen, Julie Westerlin
    Holmstroem, Rikke Boedker
    Mork, Sofie Kirial
    Pedersen, Ayako Wakatsuki
    Ehrnrooth, Eva
    Andersen, Mads Hald
    Svane, Inge Marie
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Phase I trial of personalized peptide vaccine for HLA-A24 positive patients with advanced cancer
    Terasaki, M.
    Noguchi, M.
    Naito, S.
    Uemura, H.
    Akaza, H.
    Sibui, S.
    Fujimaki, T.
    Aoki, T.
    Itoh, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Clinical and immunological analysis in a phase II trial of the glypican-3 peptide vaccine for patients with ovarian clear cell carcinoma
    Suzuki, Shiro
    Shibata, Kiyosumi
    Kikkawa, Fumitaka
    Nakatsura, Tetsuya
    [J]. CANCER RESEARCH, 2015, 75
  • [37] IMMUNE THERAPY CLINICAL-TRIAL (PHASE-I) IN AIDS ARCS PATIENTS
    PICARD, O
    IMBERT, JC
    SALAUN, JJ
    LURHAMA, Z
    MOSS, B
    GALLO, RC
    ZAGURY, D
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 134 - 135
  • [38] Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
    Murahashi, Mutsunori
    Hijikata, Yasuki
    Yamada, Kazunari
    Tanaka, Yoshihiro
    Kishimoto, Junji
    Inoue, Hiroyuki
    Marumoto, Tomotoshi
    Takahashi, Atsushi
    Okazaki, Toshihiko
    Takeda, Kazuyoshi
    Hirakawa, Masakazu
    Fujii, Hiroshi
    Okano, Shinji
    Morita, Masaru
    Baba, Eishi
    Mizumoto, Kazuhiro
    Maehara, Yoshihiko
    Tanaka, Masao
    Akashi, Koichi
    Nakanishi, Yoichi
    Yoshida, Koji
    Tsunoda, Takuya
    Tamura, Kazuo
    Nakamura, Yusuke
    Tani, Kenzaburo
    [J]. CLINICAL IMMUNOLOGY, 2016, 166 : 48 - 58
  • [39] Using Immune Response Data from a Lymphoma Vaccine Clinical Trial to Define Novel Endpoints for an Immunotransplant Trial
    Brody, Joshua
    Czerwinski, Debra
    Ai, Wei
    Levy, Ronald
    [J]. CLINICAL IMMUNOLOGY, 2009, 131 : S8 - S8
  • [40] Phase I clinical trial of DC-tumor fusion vaccine in patients with gastrointestinal cancer
    Iinuma, Hisae
    Iwasakai, Kota
    Koide, Taihei
    Tamura, Junko
    Inaba, Tsuyoshi
    Fukushima, Roji
    Watanabe, Toshiaki
    Okinaga, Kota
    [J]. CANCER RESEARCH, 2008, 68 (09)
12345